The eosinophilic esophagitis treatment market is growing rapidly due to increasing pediatric and adult diagnoses, rising use of biologics targeting IL‑5 and IL‑13 pathways, and support from gastroenterology specialists. https://www.datamintelligence.com/research-report/eosinophilic-esophagitis-treatment-market